Iovance Biotherapeutics Reiterated Buy by Jefferies Jefferies reiterated Buy on Iovance (IOVA) on Apr 10, 2026 (Investing.com); review considers market cap, event risk and peer valuation dispersion of >40% YoY.

Iovance Biotherapeutics Reiterated Buy by Jefferies: Jefferies reiterated Buy on Iovance (IOVA) on Apr 10, 2026 (Investing.com); review considers market cap, event risk and peer valuation dispersion of >40% YoY. 👈 Read full analysis #Iovance #Biotherapeutics #Investing #Jefferies #MarketCap

Antibody Therapeutics (IF=4.5, Oxford University Press)
⚡ Research Highlight - Application of a Novel LC-MS-Based Proteomic Workflow for Host Cell Protein Monitoring and Risk Control in Biotherapeutics
academic.oup.com/abt/advance-...
#antibody #LCMS #Biotherapeutics #HostCellProtein

Machine learning-powered aptamer modification—enhancing precision and therapeutic performance
www.scienceopen.com/hosted-docum...
#MachineLearning #Aptamers #Biotherapeutics #MolecularEngineering

The #Biotherapeutics Engineering Symposium concluded today with an engaging in-person session at the Uni Stuttgart.

Thanks to our speakers:
• Matthias Peipp (Kiel Uni)
• Clara T. Schoeder (Leipzig Uni)
• Janine Schuurman
…and to everyone who joined the discussions!
#ProteinEngineering

Today we kicked off the #Biotherapeutics Engineering #Symposium hosted by the Institute of Cell Biology and Immunology at Uni Stuttgart with inspiring talks:
• Mark Cragg (Uni Southampton)
• Bruno Correia (EPFL)
• Jamie Spangler (Johns Hopkins Uni)
Thanks to all speakers and participants!

teaching a NEW short course at @PEGSummit Boston on May 12 — "The Dark Proteome: Unlocking Novel Targets for Next-Gen Biologics."
join me → pegsummit.com
#DarkProteome #pegsboston #proteinengineering #antibodydiscovery #biotherapeutics #drugdevelopment #pegsummit

Human Microbiome Drugs Market Projected to Reach $2.13 Billion by 2031 The Human Microbiome Drugs Market is expected to experience significant growth, reaching $2.13 billion by 2031, driven by innovative research and advancements.

Human Microbiome Drugs Market Projected to Reach $2.13 Billion by 2031 #USA #Delray_Beach #MarketsandMarkets #biotherapeutics #Human_Microbiome

New Leadership at NanoSyrinx: Thomas J. Farrell Steps Up as CEO NanoSyrinx has appointed Thomas J. Farrell as CEO, enhancing its mission in biotherapeutics through advanced Nanosyringe technology. A strategic move for future clinical development.

New Leadership at NanoSyrinx: Thomas J. Farrell Steps Up as CEO #United_Kingdom #biotherapeutics #Coventry #NanoSyrinx #Thomas_J._Farrell

Navigating Clinical In-Use Studies: Enhancing Biotherapeutics Safety and Efficacy Join an informative webinar that focuses on clinical in-use studies crucial for ensuring biologics safety and efficacy, featuring insights from industry experts.

Navigating Clinical In-Use Studies: Enhancing Biotherapeutics Safety and Efficacy #None #biotherapeutics #Xtalks #Clinical_Studies

#PLX Secarna’s Antisense Oligonucleotide Discovery Collaboration buff.ly/XcVS2iH

#rarediseases #biotherapeutics #biologics

LinkedIn This link will take you to a page that’s not on LinkedIn

Nice workflow for cross-linked bispecific antibodies:
LysC+ProAla, Orbitrap Excedion Pro (EThcD) + Byos for disulfide mapping.
🔗 Poster below
lnkd.in/dCtstCRR
#MassSpec #Biotherapeutics

Harbour BioMed Expands Collaboration with AstraZeneca for Innovative Oncology Therapies Harbour BioMed updates its strategic partnership with AstraZeneca to expedite the development of next-gen biotherapeutics in oncology, leveraging advanced antibody technologies.

Harbour BioMed Expands Collaboration with AstraZeneca for Innovative Oncology Therapies #None #AstraZeneca #Cambridge,_Massachusetts #biotherapeutics #Harbour_BioMed

In silico investigations of albumin-GLP-1 receptor agonist complexes for diabetes drug delivery applications. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.11.007

🔗 In silico investigations of albumin-GLP-1 receptor agonist complexes for diabetes drug delivery applications. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.cs...

📚 CSBJ: www.csbj.org

#MolecularDynamics #DiabetesResearch #Biotherapeutics #DrugDelivery #Biophysics

Waters Unveils Groundbreaking Xevo Charge Detection Mass Spectrometry for Biotherapeutics Waters Corporation introduces the Xevo Charge Detection Mass Spectrometer (CDMS), revolutionizing the analysis of complex biomolecules and facilitating rapid biotherapeutic development.

Waters Unveils Groundbreaking Xevo Charge Detection Mass Spectrometry for Biotherapeutics #USA #Milford #Waters_Corporation #biotherapeutics #Xevo_CDMS

Three more pharmas join OpenFold3 AI consortium Bristol Myers Squibb, Takeda, and Astex have joined a consortium working on refining the OpenFold structure prediction platform with industry data.

#OpenFold3 #BristolMyersSquibb #Takeda #AstexPharma #OpenFoldstructurepredictionplatform #AISBconsortium #AbbVie #JnJ #Apheris #AI #molecularstructurepredictions #GoogleDeepMind #IsomorphicLabs #AlphaFold #biotherapeutics #smallmoleculediscovery #Xraycrystallography #drugdiscovery
zurl.co/jQ7qh

CYP PhD Studentships For students embarking on their research career Applications for 2026 PhD studentships in Children and Young People's cancer are open! Applications are now open! The Children and Young People's ...

Are you interested in doing a #PhD in #cancerresearch?
🧪🧑‍🔬👨🏽‍🔬👩🏿‍🔬🧫🦠🔬
Do you want to develop new #biotherapeutics?
Find cancer cures for #youngpeople?
Applications for our fully funded 4-year PhD programme starting in Autumn 2026 are open!
bit.ly/4mHbPIH
#uclcancer #QMBCI #KCLcancer_pharm #KCL #TheCrick

Black Leaders PhD programme For students of black ethnicity embarking on their research career Applications for 2026 PhD studentships are open! Application through Cancer Research UK/ Windsor Fellowship required in addition! W...

Are you interested in doing a #PhD in #cancerresearch?
🧪👩🏿‍🔬🧫🦠🔬
Do you want to develop new #biotherapeutics?
Are you of black heritage?
Applications for our fully funded 4-year BLiC PhD programme starting in Autumn 2026 are open now!
bit.ly/485QAga
#uclcancer #QMBCI #KCLcancer_pharm #KCL #TheCrick

PhD Studentships For students embarking on their research career Applications for 2026 PhD studentships are open! Applications are open! The PhD programme PhD students, funded by the CoL Centre, will follow th...

Are you interested in doing a #PhD in #cancerresearch? 🧪🧑‍🔬👨🏽‍🔬👩🏿‍🔬🧫🦠🔬 Do you want to develop new #biotherapeutics? Applications for our fully funded 4-year PhD programme starting in Autumn 2026 are open now!
bit.ly/4gS9vND
#uclcancer #QMBCI #KCLcancer_pharm #KCL #TheCrick

LabChip Plasmid DNA assay

Transform your pDNA workflows with the LabChip Plasmid DNA assay. Get purity and sizing results in under 2 minutes per sample. Learn more. ms.spr.ly/63321secSS

For research use only. Not for use in diagnostic procedures. #pDNA #plasmidDNA #biotherapeutics #LabChip

CSL Reports Significant Rise in Annual Net Profit Amid Strategic Transformation Moves CSL reports a significant increase in net profit for the year ended June 2025, driven by strong demand for plasma therapies and strategic initiatives.

CSL Reports Significant Rise in Annual Net Profit Amid Strategic Transformation Moves #Australia #Melbourne #CSL #biotherapeutics #Net_Profit

Browse Athen Research Technologies' native #proteins

purified from plasma, erythrocytes, neutrophils and other tissues for the development of #diagnostics assays, #cellculture media or the preparation of #biotherapeutics in animal models proof-of-concept studies.

🔗https://tinyurl.com/yxrwte2x

Original post on benzinga.com

Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On Calidi Biotherapeutics (NYSE: CLDI) surged 39.47% after hours Tuesday, following renewed investor interest in its innovati...

#benzinga #neuro #Biotech #Calidi #Biotherapeutics #Inc. #CLDI […]

[Original post on benzinga.com]

BioMed X Institute BioMed X Application System

Only two weeks left to apply for #ResearchFunding and join us in Ridgefield, Connecticut. Establish your own group and receive 890k USD/year for up to 5 years, access cutting-edge infrastructure!

career.bmedx.com/call/2025-RD...

#ScienceWithImpact #Ophthalmology #TissueEngineering #Biotherapeutics

Structure and function of therapeutic antibodies approved by the US FDA in 2023 Statement of Significance: Structural insights into the 12 novel therapeutic antibodies approved by the US FDA in 2023.

The review of FDA Approved Therapeutic Antibodies (2023 edition) in our journal Antibody Therapeutics received almost 12,000 downloads, and was already cited 16 times.

Thank you, Dr. Strohl, for a wonderful article.

#FDA #Biotherapeutics #Antibody

doi.org/10.1093/abt/...

Structure and function of therapeutic antibodies approved by the US FDA in 2024 Abstract. In 2024, the FDA approved 47 new molecular entities (NMEs), including 15 therapeutic antibody-based molecules, marking the 30th anniversary of th

One of the much anticipated review articles just hit the Advance Articles section in our journal Antibody Therapeutics. This is the peer-reviewed version, but before proofing and final checks.

@antibodytx.bsky.social #FDA #Antibody #Biotherapeutics

doi.org/10.1093/abt/...

The #biotherapeutics world continues progress in AI/ML design of viable #biologics.
This work highlights how NanoTemper's Prometheus Panta generates quality thermal stability data to inform their biologic developability & predictive datasets.
#Exscientia, @ox.ac.uk & @utrechtuniversity.bsky.social

Xentria Unveils Xturnpoint to Accelerate Therapeutic Innovations and Expands Headquarters Xentria, Inc. launches Xturnpoint, a studio for early-stage therapeutic innovators, alongside a significant headquarters expansion in Chicago.

Xentria Unveils Xturnpoint to Accelerate Therapeutic Innovations and Expands Headquarters #Chicago #biotherapeutics #Xentria #Xturnpoint

Brilliant poster presentations today from our 36 #MSc #Biotherapeutics students at @ucd-sbbs.bsky.social @ucddublin.bsky.social ! Impressive use of #proteomics, #statistics and #bioinformatics to tackle challenges in #drugdevelopment. Thanks to all the poster judges and for their support!

Gut bacteria heal the colon EPFL scientists have uncovered how a gut bacterium, Clostridium scindens, aids in healing intestinal injuries by restoring bile acid balance. Their findings could pave the way for new treatments for u...

An interesting publication on #biotherapeutics to restore the compromised #bileacid signaling in ulcerative colitis! check it out! actu.epfl.ch/news/gut-bac...